Wire Stories
635Enfusion Elevates Iris Xinwei Wang to Chief Strategy Officer and Lotte Tønsberg to Head of EMEA Sales and Executive Director, EMEA
Cloud-based SaaS Provider Continues Bolstering Executive Leadership Team Globally NEW YORK & LONDON & HONG KONG–(BUSINESS WIRE)–Enfusion, Inc. (“Enfusion”) (NYSE: ENFN), a...
- 912
Oceaneering’s Integrity Management and Digital Solutions Segment Announces Fourth Quarter 2021 Contracts Exceeding $80 Million
HOUSTON–(BUSINESS WIRE)–Oceaneering International, Inc. (NYSE:OII) announces that it has been awarded multiple contracts for its Integrity Management and Digital Solutions (IMDS) segment...
- 553
Venti Technologies Appoints Renowned Autonomous Vehicle Executives to Company Leadership: James Fu and Demian Chong to Help Scale Company’s Autonomous Logistics Business
Pioneers in self-driving technology including globally operating autonomous fleets BOSTON–(BUSINESS WIRE)–Venti Technologies, the leader in safe-speed autonomous vehicles logistics systems, today announced...
- 751
Zai Lab Announces NDA Acceptance of Margetuximab for Patients with Pretreated Metastatic HER2-Positive Breast Cancer in China by the NMPA
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused,...
- 641
Tier-1 Mobile Network Carrier in Japan Expanding Their 4G Cellular Network with Gilat’s Backhaul over Satellite
Gilat receives order for additional VSATs to enable the operator’s 4G/LTE network growth PETAH TIKVA, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) —...
- 602
BeiGene to Present at the J.P. Morgan 40th Annual Healthcare Conference
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$bgne #JPMconference–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global science-driven biotechnology company, today announced that the...
- 784
Allay Therapeutics Establishes Corporate Headquarters in the Bay Area and Expands Base of Operations in Singapore
MENLO PARK, Calif.–(BUSINESS WIRE)–Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, today announced...
- 765
China NMPA Approves Tislelizumab as Second- or Third-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Tislelizumab is now approved in six indications in China This marks tislelizumab’s third approved lung cancer indication in China and first in...
- 728
AJC to Host “BIMP-EAGA Tourism Webinar -Japanese market insights and trends post-COVID-19-” on January 12, 2022
TOKYO–(BUSINESS WIRE)–The ASEAN-Japan Centre (AJC) will organize a webinar for tourism stakeholders in Brunei Darussalam-Indonesia-Malaysia-Philippines East ASEAN Growth Area or BIMP-EAGA on...
- 617
UMC Reports Sales for December 2021
TAIPEI, Taiwan–(BUSINESS WIRE)–United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today reported unaudited net sales for the month of December 2021. Revenues...
